Bailard’s ImmuCell ICCC Stock Holding History

Bailard’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$99K	Hold	10,102	–	–	﹤0.01%	739
2026 Q2	$102K	Hold	10,102	–	–	﹤0.01%	758
2026 Q1	$63.9K	Buy	+10,102	New	+$64.7K	﹤0.01%	734

Bailard's ICCC Position: Q3 2026 in Review

Bailard held its ImmuCell (ICCC) position steady in Q3 2026 at 10,102 shares worth $99K. The position accounts for ﹤0.01% of the portfolio, ranked #739.

Bailard first reported a position in ICCC in Q1 2026 and has held it in 3 quarters since. The position peaked at $102K in Q2 2026. 1 fund tracked by Wall St. Rank holds ICCC as of Q3 2026.

Bailard held 10,102 shares of ImmuCell worth $99K as of Q3 2026.
Bailard left its ImmuCell share count unchanged in Q3 2026.
ImmuCell made up ﹤0.01% of Bailard's portfolio in Q3 2026, its #739 holding.
Bailard first reported a position in ImmuCell in Q1 2026 and has held it in 3 quarters since.
Bailard's ImmuCell position peaked at $102K in Q2 2026.
1 fund tracked by Wall St. Rank held ImmuCell as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.